RHEB and Alzheimer disease: Therefore, although further research is necessary to determine the clinical applicability of AAV1-Rheb(S16H) transduction to treat neurodegenerative diseases, this approach may be a useful strategy to protect neurons in the lesioned brain, and it may have beneficial effects in patients with neurological disorders, such as AD and PD.